AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| BDE | Ann:Reinstatement to official quotation (Price Sensitive) | 23/04/18 | 0 | 29 | |||
|
|||||||
| BDE | Ann:2017 Annual Report (Price Sensitive) | 20/04/18 | 0 | 27 | |||
|
|||||||
| BDE | Ann:Voluntary request for suspension (Price Sensitive) | 29/03/18 | 0 | 104 | |||
|
|||||||
| BDE | Ann:Preliminary Final Statement - 31 December 2017 (Price Sensitive) | 18/03/18 | 0 | 112 | |||
|
|||||||
| BDE | Ann:Change of Director | 13/03/18 | 0 | 77 | |||
|
|||||||
| BDE | Ann:Director Declaration - Jueming Sang | 13/03/18 | 0 | 75 | |||
|
|||||||
| BDE | Ann:Initial Directors Interest - Jueming Sang | 13/03/18 | 0 | 72 | |||
|
|||||||
| BDE | Ann:Final Directors Interest - Chao Liu | 13/03/18 | 0 | 77 | |||
|
|||||||
See All Discussions
NSX News